The Effect of Lavender Inhalation on Anxiety, Sleep, and Blood Pressure
ConditionPrimary Hypertension
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorArdahan University
About this trial
This study aims to determine the effects of lavender oil inhalation on anxiety, sleep quality, and blood pressure in patients with primary hypertension. The study is designed as a double-blind randomized controlled trial. The study population consists of patients presenting to the Cardiology Outpatient Clinic of Ardahan State Hospital. Participants are randomly assigned to an experimental group, which will receive a total of 12 lavender oil inhalations three times a week for one month, or to a control group, which will continue routine treatment and care. Data will be collected using the Hypertension Diagnostic Form, Beck Anxiety Inventory, and Pittsburgh Sleep Quality Index. Statistical analyses will be conducted to compare outcomes between the experimental and control groups.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with primary hypertension
Willing to participate in the study
No allergy to lavender
No olfactory impairments
Disqualifiers
Communication difficulties
Unwilling to participate
Using other herbal or aromatherapy treatments
History of sleep disorders affecting sleep quality (e.g., obstructive sleep apnea)
Trial design
Design model
Parallel
Treatments tested in this trial
Lavender
Other interventionParticipants receive lavender oil inhalation three times per week for one month (total of 12 sessions) using a standardized diffuser. This intervention is provided in addition to routine care for primary hypertension. Outcomes measured include anxiety, sleep quality, and blood pressure before and after the intervention.
Treatment groups
50 Participants
are divided into 2 treatment groupsGroup A: experimental groupExperimental treatment 1 intervention
Group B: Routine care onlyNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Anxiety
Measured using the Beck Anxiety Inventory (BAI) at baseline, week 2, and week 4. Higher scores indicate higher anxiety.
Time frame
Baseline, Week 2, Week 42
Blood Pressure
Measured using the Hypertension Diagnostic Form at baseline, week 2, and week 4. Includes systolic and diastolic measurements.
Time frame
Baseline, Week 2, Week 4Secondary outcomes
1
Sleep quality
Measured using the Pittsburgh Sleep Quality Index (PSQI) at baseline, week 2, and week 4. Higher scores indicate poorer sleep quality
Time frame
Baseline, Week 2, Week 4Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov